Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Cigna

Community Health Systems

HCA Healthcare

Tenet Healthcare

UnitedHealth Group

Insurer and hospital stocks fell ahead of a legal showdown over the constitutionality of the Affordable Care Act before a three-judge federal appeals court.

Health-care stocks fall ahead of court arguments over constitutionality of Obamacare

Anthem

Hospital and health insurers' lose on Trump's executive order to unveil price of services to patients.

Healthcare Tumbles on Trump's Price Disclosure Order

Centene

News that a Centene-Humana deal isn't in the works has CNC stock falling on Monday after an official statement was made by Humana.

Centene-Humana Deal? Nope. CNC Stock Slides on the News

Health insurer Humana (NYSE: HUM) confirmed it will not make a proposal to combine with Centene (NYSE: CNC) as an alternative to Centene’s planned acquisition of WellCare Health Plans (NYSE: WCG), according to Reuters.

Humana Won't Make An Offer For Centene

Fiserv

Alphabet

NIKE

SS&C Technologies Hlds

US Foods Holding

Lee Ainslie (Trades, Portfolio), manager of Dallas-based Maverick Capital, disclosed this month his top six buys for the first quarter included four new positions and increased bets in the following two companies: Google parent Alphabet Inc. and sports apparel giant Nike Inc.

Lee Ainslie’s Top 6 Buys of the 1st Quarter

Humana (HUM) reported earnings 30 days ago. What's next for the stock?

Why Is Humana (HUM) Up 0.2% Since Last Earnings Report?

Abbott Labs

Autodesk

Salesforce

Intel

Medtronic

Microsoft

NVIDIA

Texas Instruments

To show how business can and must cultivate a Culture of Health, JUST Capital has released new analysis, with support from Robert Wood Johnson Foundation, evaluating how companies perform on core issues of community health.

The Companies Leading On Health For Communities And Families

Health care plan stocks have made a remarkable recovery after a brutal month of selling in April. Play the turnaround using these trading tactics.

Health Care Plan Stocks Stage Healthy Breakout

Humana (HUM) rides high on solid Medicare business growth and its strategic efforts. The stock holds immense potential to reap solid benefits for investors.

Why You Should Hold Humana (HUM) Stock in Your Portfolio

Humana Inc. (HUM) CEO Bruce Broussard on Q1 2019 Results - Earnings Call Transcript

Humana (HUM) delivered earnings and revenue surprises of 4.19% and 1.99%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Humana (HUM) Beats Q1 Earnings and Revenue Estimates

Humana's (HUM) first-quarter earnings benefit from Medicare Advantage membership growth and robust revenues.

Humana (HUM) Q1 Earnings & Revenues Beat Estimates, SurgeY/Y

Humana CEO Bruce Broussard told investors Wednesday the insurer "does not support any bill" that would eliminate Medicare Advantage or "make private insurance illegal."

Another big private insurer just vowed to fight 'Medicare for All' plans in Washington

Humana's (HUM) first quarter earnings gain on the back of higher revenues.

Humana's (HUM) Q1 Earnings and Revenue Beat Estimates

Humana Inc. reported first-quarter earnings and revenue on Wednesday that topped Wall Street expectations, while also raising its full-year guidance.

Humana tops first-quarter revenue and earnings expectations

The healthcare sector is amongst the worst performing sectors of 2019 to date, thanks in large part to scrutiny of drug prices, PBMs and the threat of state sponsored Medicare.

Humana Set To Recover Losses, Or Will Medicare For All Threat Stifle Share Price Until 2020, And Beyond?

Humana's (HUM) Q1 earnings are likely to gain on higher membership and a solid Medicare Advantage.

Is a Beat in the Offing for Humana's (HUM) Q1 Earnings?

Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Humana (HUM) is Poised to Beat Earnings Estimates Again

Molina Healthcare

Healthcare stocks suffered declines in the Medicare-for-All policy and revving up of drug price rebate.

Healthcare Stocks in Focus on Regulatory and Political Risk

CVS Health

The Senate Finance Committee on Tuesday grilled executives of five of the health care industry's top pharmacy benefit management companies over skyrocketing drug costs in the U.S.

Senators grill CVS Health, Cigna, Humana on rising drug costs: Time to 'get beyond the blame game'

Executives from the nation's largest pharmacy benefit managers denied that so-called "backdoor deals" with drug manufacturers are responsible for the high prices patients pay for drugs.

CVS, Cigna, Humana blame Big Pharma for high drug prices in Senate hearing

Humana Inc. is a leading US healthcare and insurance company.

Humana Inc: An Intact Growth Story For A Decent Price?

Humana's (HUM) subsidiary to launch medical care centers at 10 more sites to take care of more seniors.

Humana's Arm to Open 10 Medical Centers to Serve Seniors

WellCare Health Plans

Here's what you need to know before investing in health insurance stocks this year.

Top Health Insurance Stocks for 2019

The game theory comes in with the timing of when new rules might be adopted. Executives note the deadline for filing 2020 plans is in early June.

News for Humana Stock (HUM)